In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo

Gunter Schuch, Marcelle Machluf, Georg Bartsch, Masashi Nomi, Henri Richard, Anthony Atala, Shay Soker

Research output: Contribution to journalArticlepeer-review

115 Scopus citations

Fingerprint

Dive into the research topics of 'In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds